1-14 of 14 Search Results for

pbm

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Journal Article
Journal of Health Politics, Policy and Law (1 October 2008) 33 (5): 943–963.
Published: 01 October 2008
...Christy A. Rentmeester; Robert I. Garis How ought we determine whether businesses in the health care sector profit fairly? One class of companies in the health care sector, pharmacy benefit managers (PBMs), deserves special consideration. We describe two specific revenue-generating practices...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2008) 33 (5): 975–978.
Published: 01 October 2008
... to John Malley’s commentary, we offer one minor clarifica- tion, one more significant clarification, and one more detailed expansion on how PBMs interact with employers. First, in our article, we point out that rebate values and drug prices are considered proprietary; we state, “the formula...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2008) 33 (5): 965–973.
Published: 01 October 2008
... Robert I. Garis falls short of identifying the fact that not every PBM relies on spread pricing as revenue stream. Several PBMs in the marketplace today offer complete pass-through pricing. Some of those companies also offer “cost plus” pric- ing through mail. Under these pricing models, there is...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2008) 33 (5): 859–860.
Published: 01 October 2008
... difficult arena. The issue then presents a debate on whether various practices engaged in by pharmaceutical benefit companies (PBMs) inappropriately raise the price of drugs (and thus indirectly reduce access to their utilization). Christy Rentmeester and Robert Garis begin by arguing that PBMs get...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2008) 33 (5): 1021–1025.
Published: 01 October 2008
... receiving his doctorate in 1999. He is currently an associate professor in the Pharmacy Sciences Department and director of the Non- traditional Doctor of Pharmacy Program. His research interests include the phar- macy benefit management (PBM) industry and the costs of health care services. Garis...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2011) 36 (2): 295–316.
Published: 01 April 2011
... pharmacies at ex-­wholesaler prices; and outpatient pharmacies dispense the drugs to patients at retail (or “public”) prices. Outpatient pharmacies are reimbursed by the patient’s pharmacy benefit manager (PBM) or health plan, net of the patient’s co-­payment. PBMs do not observe the actual...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2006) 31 (3): 437–472.
Published: 01 June 2006
Journal Article
Journal of Health Politics, Policy and Law (1 October 2006) 31 (5): 887–944.
Published: 01 October 2006
Journal Article
Journal of Health Politics, Policy and Law (1 August 2005) 30 (4): 719–750.
Published: 01 August 2005
Journal Article
Journal of Health Politics, Policy and Law (1 August 1999) 24 (4): 705–713.
Published: 01 August 1999
... discounts items Macro DRG-based Case rates for PBM contracts payments chronic illness for drug prices management without...
Journal Article
Journal of Health Politics, Policy and Law (1 February 2003) 28 (1): 109–132.
Published: 01 February 2003
... the purchasing power of the state’s Medicaid program to lower drug prices. As LD 2599 picked up momentum in March, the department’s prescrip- tion drug purchasing group focused its work on developing a state phar- macy benefit manager (PBM) and other state powers to contain prescrip- tion drug...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2006) 31 (3): 423–435.
Published: 01 June 2006
... management companies [PBMs but the degree of nonoverlap between the issues of concern to policy makers and those of concern to academic commentators is still striking. So long as the two sides are focused on different issues, there will be significant translational difficulties in using academic...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2001) 26 (2): 291–326.
Published: 01 April 2001
... managers (PBMs) not by MCOs (Titlow et al. 2000; Rosoff 1998). Indeed, a recent survey found that MCOs rely on information provided by PBMs, including CEA, literature reviews, drug utilization reviews, and recommendations for disease management programs...
Journal Article
Journal of Health Politics, Policy and Law (1 August 2002) 27 (4): 543–574.
Published: 01 August 2002